Current Trends and Future Growth in Rehabilitation Equipment Market

Since the enactment of the long-term care insurance system in 2000, public interest in rehabilitation equipment, and thereby the number of users has increased. This trend further resulted into improvements in the function and design of such equipment, which greatly benefits the aged population and physically challenged to achieve greater independence and participate in society. Rehabilitation equipment is a re-usable aid which assists the patient with their daily activities.

In the past decade, the market for these devices has expanded considerably due to government support and technological advancements to address the needs of the increasing geriatric and physically challenged population in developed countries with the purchasing power as well as need for rehabilitation equipment. However, high cost and maintenance expenses may hinder the growth of this market in developing and under-developed countries, which is otherwise estimated to be significant. This could be attributed to the entry of various government and private insurance players who cover various assistive devices under reimbursement plans, making them more affordable to consumers and enhancing the demand for them in the market. The combined effect of these factors is predicted to drive the rehabilitation equipment market during the forecast period.

Obtain Report Details: http://www.transparencymarketresearch.com/rehabilitation-equipment-market.html

The global market is segmented on the basis of product into the following categories: personal care aids, mobility devices, exercise equipment, respiratory & pressure care products, and other. The mobility devices segment, which is expected to register high growth in the near future, covers wheelchairs, scooters, and walking assistance devices. Wheelchairs are designed for physically challenged customers who face problems with mobility. The elderly and individuals with leg injuries, spinal cord injuries (SCIs), multiple sclerosis (MS), hemiplegia & other types of paralysis, cerebral palsy (CP), spinal bifida, amyotrophic lateral sclerosis (ALS), lower limb amputees, and arthritis are major customers too. There are wheelchairs specially designed to perform in different infrastructural setups. Physically challenged sportspersons are also a major target segment for wheelchair manufacturers. Additionally, with advancements in technology, wheelchairs feature Bluetooth, Wi-Fi connectivity, and smart gadget access, which allow the users to lead a modern lifestyle.

By application, the global rehabilitation equipment market is divided into two groups: physiotherapy and occupational therapy. The former is anticipated to hold a major market share owing to the increasing need for it among the aging population. Human life expectancy has increased worldwide due to general health consciousness and advancements in medical science to deal with fatal diseases. The total world population in 2014 was beyond 700 billion and is anticipated to rise to 714 million in 2020.

In terms of end-user, the global rehabilitation equipment market is categorized into hospitals & clinics, ambulatory surgery centers, home health care, long-term care centers, and others. Hospitals & clinics are projected to constitute a prominent market share, while home health care is estimated to witness a major CAGR during the forecast period.

Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=23729

Geographically, North America is likely to account for a major share in the global rehabilitation equipment market during the forecast period. The rising preference for an independent lifestyle, the elderly and physically challenged individuals’ need to explore the world, increased longevity, and the staggering cost of caregiver services have fuelled the demand for mobility devices globally, apart from increased government support and reimbursement facilities. Moreover, recent industry estimates suggest that over 1,60,000 people in the U.S. use electric wheelchairs and scooters.

Key players operating in the global market include Amigo Mobility International, Inc., Argo Medical, Access Rehabilitation Group, GF HEALTH PRODUCTS, INC., Stryker Corporation, Medline Industries, Inc., Invacare Corporation, Dynatronics Corporation, Drive DeVilbiss Healthcare, and Caremax Rehabilitation Equipment Co. Ltd.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

 

Surgical Microscopes Market 2017-2025 Value Share, Analysis and Segments

A surgical microscope or operating microscope is an electrically or mechanically operated optical microscope designed specifically to perform microsurgeries in a surgical setting. It provides magnification (typically ranging from 4x–40x), illuminated image, and stereoscopic vision of the surgical area. Surgical microscopes mainly offer a strain-free procedure to surgeons. Their components are designed to sterilize or disinfect easily to avoid cross infection. The modern operating or surgical microscope can be placed on a surface such as a table top, mounted on a stand, or worn by the surgeon on the head. In a surgical suite with limited space, it can be hung on the wall or ceiling to conserve floor space. It enables students, staff, as well as the patient to gain a better view of the target site, along with the surgeon.

Obtain Report Details: http://www.transparencymarketresearch.com/surgical-microscopes-market.html

The global surgical microscope market is expected to develop substantially due to the rising prevalence of chronic diseases and adoption of microsurgeries or minimally invasive surgeries. Demand for them is predicted to drive the market for surgical microscopes as they play a critical role in these surgeries. The geriatric population is highly susceptible to several chronic disorders and age-related problems, which is likely to aid the expansion of the market. Furthermore, advancements in health care infrastructure and research & development in life sciences are predicted to drive the market. Rapid technological advancements in surgical microscopes regarding visibility, portability, stability, adoption of fluorescence image-guided surgery (FIGS), and addition of innovative features such as the red reflex stability, augmented microscopy, and wide angle view are anticipated to propel the market during the forecast period.

However, the high cost of the microscope leading to its low acceptance may restrain the market in some regions, apart from the heavy custom duties on medical instruments and excise tax implementations by the U.S. government. The dearth of skilled professionals and inadequate technical knowledge may lead to sluggish development of the global surgical microscope market.

The market can be segmented on the basis of application into the following categories: ophthalmic surgeries, neurosurgery, ENT surgeries, plastic & reconstructive surgery, spine surgery, dentistry, gynecology (also colposcopes for diagnostics in gynecologic treatments), and urology. Ophthalmology is the dominant segment due to growing concerns over vision & eyesight, increasing prevalence of eye disorders, and rising population opting for ophthalmology surgeries globally. The ENT segment is projected to advance significantly owing to the mounting preference for minimally invasive surgeries for ENT, high prevalence of disorders such as sinusitis, and supportive reimbursement plans. In terms of end-user, the global surgical microscope market can be divided into the following groups: hospitals, specialty clinics, and ambulatory surgical centers.

Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=23702

Geographically, the market can be distributed over five major regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominated the surgical microscope market, owing to the sophisticated health care services and supportive reimbursement policies for medical treatments enabling greater usage of the instrument in the region. Moreover, the rising incidence of chronic diseases and higher adoption of minimally invasive surgeries play a role too. Asia Pacific is estimated to expand rapidly on account of the increasing geriatric population, advancements in health care facilities, and supportive medical reimbursement programs in emerging countries such as India and China. Asia Pacific and Latin America are lucrative target areas for major key players of the surgical microscope market.

These include Carl Zeiss AG, Leica Microsystems (Danaher Corporation), Topcon Medical Systems, Inc. (Topcon Corporation), Haag-Streit Group, Novartis AG, Takagi Seiko Co Ltd., and Global Surgical Corporation.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

 

Bioabsorbable Stents Market will explore robust size & growth during 2017-2025

A stent is a small mesh tube (net-like material with space in it) used for the treatment of blockades of the arteries in the heart. The stent plays a vital role in the medical field of cardiology. These devices are generally made of metallic or plastic tubes which are fixed into the lumen of an anatomic vessel to keep it open for blood flow. Arteries of the heart consist of blood vessels that carry blood from the heart to other parts of the body. Stents are placed in the artery for the removal of blockades in the heart as a part of surgical procedure called the percutaneous coronary intervention. Stents help to keep the arteries open and reduce the chance of heart attacks. Traditionally, stents are made of metal mesh and remain in the body permanently until they are removed through surgical intervention. But nowadays, bioabsorbable stents, also known as biodegradable stents, are made of materials which get dissolved or absorbed in the body. A bioabsorbable stent has no permanent implant. It gets gradually resorbed and benignly cleared from the body.

Obtain Report Details: http://www.transparencymarketresearch.com/bioabsorbable-stents-market.html

On the basis of product type, the bioabsorbable stents market can be classified into polymeric bioabsorbable stents and metallic bioabsorbable stents. The polymeric bioabsorbable stents segment is expected to grow faster than the metallic bioabsorbable stents segment during the forecast period. The polymers are extensively used in cardiovascular devices and act as delivery vehicles for drug coatings. The bioabsorbable polymer helps in late thrombotic events and reduces the need for enlarge dual anti-platelet therapy. Poly-L-lactic acid, polyglycolic acid, and polycaprolactone are some of the polymers used in polymeric bioabsorbable stents. Metallic bioabsorbable stents are generally composed of magnesium and iron. On the basis of application, the market is classified as coronary artery disease and peripheral artery disease. The coronary artery disease segment is anticipated to grow at a high rate as compared to the peripheral artery disease segment. Increasing demand for bioabsorbable stents that can be used in coronary procedures and growing preference for minimally invasive surgical procedures are the factors driving the market growth of the coronary artery disease segment. Increasing obese population and high prevalence of coronary and peripheral artery diseases are the key drivers of the global bioabsorbable stents market. However, stringent regulatory scenario, due to which only a few products have been approved till now, is hindering the growth of this market. In addition, high cost of devices and drawbacks such as local inflammation, recoil after expansion, crossing issues, and difficulty in visualizing a non-metallic stent on fluoroscopy are restricting the growth of the market. Low cost treatment and accurate stent placement can attract patients to adopt bioabsorbable stents for disease management.

Geographically, North America and Europe dominate the global bioabsorable stents market owing to increased awareness for the treatment of coronary ailments and growing aging population. Moreover, according to Epidemiological projections, approximately 27 million people in North America and Europe suffer from peripheral artery disease. The Asia Pacific market is projected to grow with rising population of extended levels of cholesterol that would be expected to contribute a major increase in the general burden of cardiovascular diseases in this region which helps to grow the bioabsorable stents market. The market in Africa is projected to grow owing to rise in disposable income and development of health care infrastructure along with increase in health care spending.

Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26879

Key players operating in the global bioabsorbable stents market include Abbott Laboratories, REVA Medical, Elixir Medical Corporation, Biotronik, Meril Life Sciences, Kyoto Medical Planning Co. Ltd, and Arterius Limited.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

 

Biological Safety Cabinates Market Analysis and Outlook up to 2025

Biological safety cabinets, are enclosed ventilated workstations that facilitate safe handling of biological samples, contaminants, and other potentially hazardous materials from exposure to biohazards and cross contamination during laboratory procedures. These are also referred to as biosafety cabinets or microbiological safety cabinets. The primary purpose of these biological safety cabinets is to provide protection to personnel, products, and working environment from biological containments and other hazardous material contained within and surrounding the cabinets. Biological safety cabinets are designed to provide different levels of protection in order to obtain optimum control over product quality by reducing potential risk of exposure to biohazards materials. There are three different classes of biological safety cabinets in the market based on the need for specific application and level of bio-containment required. Increasing number of clinical research organizations due to upsurge in R&D activities in last decade and increasing pressures of minimizing level of contamination and errors are anticipated to drive the market for global biological safety cabinets.

Obtain Report Details: http://www.transparencymarketresearch.com/biological-safety-cabinates-market.html

Biological safety cabinets are widely used by R&D organizations, scientific laboratories, and medical and clinical research institutes and related organizations. The global biological safety cabinets market is estimated to expand due to increased R&D budget by governments as well as commercial players for new product development and to serve the unmet needs in the medical and healthcare sector. The increase in R&D budgets is likely to create new opportunities for the establishment of new research labs and expansion of existing facilities, which is anticipated to increase the demand for biological safety cabinets. Current trends of laboratory automation for sample preparation, storage, and movement of samples and related products has improved the work efficiency with less human errors and minimized levels of contamination. Technological advancements in development of automated biological safety cabinets provides the integration of laboratory accessories and other instruments, which minimizes the need for human manipulations and improves product as well as personnel safety. Moreover, key factors that are likely for propel the global biological safety cabinets market are increasing demand for laboratory automation processes and integration of lab services with enhanced product quality. However the high cost of biological safety cabinets, safety issues, and lack of skilled professionals for operating and maintaining biological safety cabinets are estimated to hinder the expansion of the market during the forecast period.

The global biological safety cabinet can be segmented into type of biological safety cabinet, end-user, and geography. In terms of type of biological safety cabinet, the market can be segmented into Class I, Class II, and Class III safety cabinets. These cabinets are provided with high efficiency particulate air filters in their exhaust and or supply systems. Class I cabinets provide protection to personnel and environment and not to products and sample. Class II biological safety cabinets are further classified into type A1, type A2 and type B1, type B2. Class III cabinets are gas-tight enclosures with non-opening view window designed to work with high risk biological agents and provide maximum protection for environment and personnel. In terms of end-user, the biological safety cabinets market can be segmented into clinical and contract research organizations, pharmaceutical and biotechnological companies, educational institutions, and general healthcare institutions.

Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26882

In terms of geography, the global biological safety cabinets market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global biological safety cabinets market due to advanced healthcare infrastructure and availability of skilled professionals in the region. It is projected to maintain its dominance during the forecast period. Europe follows North America in terms of market share in the global market. The European Union (EU) has set a target of raising R&D investments to 3 % of GDP by 2020. Asia Pacific is projected to expand at a significant CAGR during the forecast period due to increased R&D expenditure by the governments and commercial players in the region. According to the UNESCO Institute for Statistics’ new data tool, China has increased its R&D budget by 18.03 % over 2015. The increased R&D budgets by India, China, South Korea, & Japan are likely to drive the growth of this market during the forecast period.

Key players operating in the global biological safety cabinets market include Germfree Laboratories, Inc., NuAire, Thermo Fisher Scientific Inc., Erlab DFS, Esco Micro Pte Ltd., MRC ltd., Labconco Corporation, The Baker Company, Kewaunee Scientific Corporation, and BIOBASE Group. Companies are focusing on development of automated biological safety cabinets to enhance work flow efficiency and minimize human errors.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

 

Blood Viscometer Market Trends, Regulatory Landscape and Operational Strategies 2025

The measurement of the viscosity of blood is done by using a blood viscometer. Rheometer measures the viscosity of a fluid with various flow conditions, whereas, viscometers measure the viscosity with one flow condition. The applications of the blood viscometer are to diagnose the viscosity of the blood which is helpful in diagnosis of all known risk factors related to cardiovascular diseases, which include high blood cholesterol, pressure, smoking, diabetes and other cardiovascular diseases. This helps predict cardiovascular diseases, and ultimately, the viscosity of the blood can be improved with the help of the medication from experts. Not only the blood viscometer helps in the prediction of cardiovascular diseases but also, other major diseases such as Alzheimer’s disease, migraines, diabetes, gout, and rheumatoid arthritis.

Obtain Report Details: http://www.transparencymarketresearch.com/blood-viscometer-market.html

Viscosity can be determined over a wide range of shear stresses, as infrared sensors are incorporated in the new capillary blood viscometer. The blood viscometer is designed in such a way that the blood flows through the capillary and the flow of the blood varies according to the time. In the blood viscometer there is an air chamber which has a suitable transducer to measure the pressure and the pressure varies according to the time. The blood flows through a compliant membrane to the sample in a fixed volume air chamber due to pressure. In the capillary, the air pressure controls the instantaneous shear stress of the blood, whereas pressure, which is time derivative, controls the instantaneous shear rate. Nonlinear sample viscosity determines the entire blood flow resistance. The air chamber comprises two parts, which can be disconnected from each other. This allows the easy discard of the blood containing part of the instrument, eliminating the cleaning and handling of blood-contacted components. There is no need of anticoagulants, as the entire process is completed within a minute.

The driving forces of the market for blood viscometer include simplicity in usage, requirement of one run and small test sample volume, short measuring time, viscosity can be measured over a range of shear rates, and the non-requirement of anticoagulants. The advancements and developments in research of the blood viscometer have led to overcoming of the challenges posed by the traditional viscometer or rheometer methods. This, in turn, has led to the significant demand for these devices, thereby driving the market for the blood viscometer. Rising threat of various cardiovascular diseases, Alzheimer’s disease, migraines, diabetes, gout, and rheumatoid arthritis has greatly increased the demand for blood viscometers across the globe. However, the advancements in the research and development of other methods of prediction of cardiovascular diseases and other diseases have proven to be restraints for the blood viscometer market.

In terms of product type, the global blood viscometer market can be segmented into rotational viscometer, capillary viscometer, and other instruments. In terms of end-user, the blood viscometer market can be segmented into clinics, hospitals, laboratories, and others.

Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26885

Geographically, the global blood viscometer market can be segmented into North America, Latin America, Europe, Asia Pacific, & Middle East & Africa. North America dominates the global blood viscometer market in 2016, as there are significant investments in research and development of blood viscometers which has led to production of the advanced and developed blood viscometers resulting in whooping considerable demand for blood viscometer products in the region. The market in Asia Pacific is estimated to expand due to the population pool especially in countries like India and China, and spreading awareness about the blood viscometer’s wide applications.

Key players operating in the blood viscometer market include Thermo Fisher Scientific, Anton Paar, RheoSense, Brookfield, BioFluid Technology, Health Onvector, Lamy rheology, Lauda, Benson Viscometer, and HRD.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.